Bone loss in HIV, COVID-19, rheumatoid arthritis, and osteoporosis is linked to damaged mitochondria in bone cells. Current therapies target the matrix but not the dysfunctional cells that perpetuate the damage. Our project uses mesenchymal stem cells to deliver healthy mitochondria, restoring energy production and cellular function — a regenerative strategy to reverse bone degeneration at its root.